Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
52-week range
$0.01 – $0.32
0% from low
Exchange
OTC Link
ADRC
Borrow rate
45.90%
Hard to borrow
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|
| Revenue | $901.6M | $645.6M | $670.1M | $682.6M | $755.7M | $703.2M |
| Cost of revenue | $356.8M | $376.1M | $314.5M | $360.5M | $417.9M | $378.0M |
| Gross profit | $544.8M | $269.5M | $355.6M | $322.0M | $337.8M | $325.1M |
| Gross margin | 60.4% | 41.7% | 53.1% | 47.2% | 44.7% | 46.2% |
| R&D | $0 | $0 | $0 | $0 | $0 | $0 |
| Operating income | −$196.5M | −$342.2M | −$21.3M | −$48.8M | −$4.0M | $5.1M |
| EBITDA | −$123.9M | −$554.9M | −$11.1M | $25.3M | $73.3M | $62.4M |
| Net income | −$235.5M | −$586.6M | −$76.2M | −$37.4M | −$19.9M | −$51.9M |
| Net margin | -26.1% | -90.9% | -11.4% | -5.5% | -2.6% | -7.4% |
| EPS (diluted) | -32.49 | -80.04 | -8.37 | -2.55 | -1.26 | -3.36 |
Annual figures · source: Financial Modeling Prep
| Year | Est. revenue | Est. EPS | EPS range | # Analysts |
|---|---|---|---|---|
| 2026 | $951M | $4.04 | $4.04–$4.04 | 1 |
| 2027 | $924M | $0.93 | $0.93–$0.93 | 1 |
| 2028 | $1.2B | $0.90 | $0.90–$0.90 | 1 |
| 2029 | $1.2B | $0.99 | $0.99–$0.99 | 1 |
Forward consensus · source: Financial Modeling Prep
AESTHETIC MEDICAL SP/ADR
No one on the platform currently holds PAIYY.
No tracked institution reports a position in PAIYY as of their last filing.
No one on the platform has traded PAIYY yet.
| +0.00% |
| $2M |
| — |
| PKTXProtoKinetix, Incorporated | $0.01 | -16.39% | $2M | — |
| PLLWFPolarean Imaging plc | $0.01 | +0.00% | $8M | — |
Source: Financial Modeling Prep · peers by sector/industry
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.